Cargando…

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice

The aim of the present study was to explore the protective effects of Berberine (BBR) against non-alcoholic steatohepatitis (NASH). Male 4-week-old C57BL/6J Apolipoprotein E-deficient (ApoE(−/−)) mice were divided into the following three groups, which were given different diets: Normal chow diet (S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jin, Ma, Xiao-Jie, Li, Ling, Wang, Lei, Chen, Ying-Gi, Liu, Jing, Luo, Yan, Zhuang, Zhen-Jie, Yang, Wen-Jun, Zang, Shu-Fei, Shi, Jun-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647746/ https://www.ncbi.nlm.nih.gov/pubmed/29075339 http://dx.doi.org/10.3892/etm.2017.5051

Ejemplares similares

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice
por: Chen, Junwen, et al.
Publicado: (2014)

Western Diet-Fed ApoE Knockout Male Mice as an Experimental Model of Non-Alcoholic Steatohepatitis
por: Camargo, Felipe N., et al.
Publicado: (2022)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Estradiol Protects Female ApoE KO Mice against Western-Diet-Induced Non-Alcoholic Steatohepatitis
por: Araujo, Layanne C. C., et al.
Publicado: (2023)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Lysosomal-associated protein transmembrane 5 ameliorates non-alcoholic steatohepatitis by promoting the degradation of CDC42 in mice
por: Jiang, Lang, et al.
Publicado: (2023)

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
por: Wu, Min, et al.
Publicado: (2020)

Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats
por: Ghareeb, Doaa A., et al.
Publicado: (2015)

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
por: Jian, Jie, et al.
Publicado: (2022)

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe((−/−)) mice
por: Ma, Xiaolei, et al.
Publicado: (2020)

Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice
por: Xu, Jia, et al.
Publicado: (2022)

MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice
por: Yang, Ya-Ling, et al.
Publicado: (2019)

Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation
por: Inia, José A., et al.
Publicado: (2023)

Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice
por: Xue, Mei, et al.
Publicado: (2015)

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice
por: Wang, Wen-yi, et al.
Publicado: (2011)

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
por: Fishman, Pnina, et al.
Publicado: (2019)

Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe (−/−) mice with hyperhomocysteinemia
por: Li, Hongjun, et al.
Publicado: (2016)

Alcohol Binge Drinking Selectively Stimulates Protein S-Glutathionylation in Aorta and Liver of ApoE(−/−) Mice
por: Seidel, Kerstin, et al.
Publicado: (2021)

Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
por: Wang, Yanyan, et al.
Publicado: (2021)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
por: Zigmond, Ehud, et al.
Publicado: (2014)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2020)

GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress
por: Kim, Hyeon Ju, et al.
Publicado: (2020)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
por: Zhu, Qingfu, et al.
Publicado: (2022)

Amelioration of Non-Alcoholic Steatohepatitis by Atractylodes macrocephala Polysaccharide, Chlorogenic Acid, and Geniposide Combination Is Associated With Reducing Endotoxin Gut Leakage
por: Leng, Jing, et al.
Publicado: (2022)

The phytochemical polydatin ameliorates non‐alcoholic steatohepatitis by restoring lysosomal function and autophagic flux
por: Chen, Xiaoting, et al.
Publicado: (2019)

Glucosinolates Extracts from Brassica juncea Ameliorate HFD-Induced Non-Alcoholic Steatohepatitis
por: Sheu, Ming-Jen, et al.
Publicado: (2023)

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
por: Yang, Zhen, et al.
Publicado: (2023)

Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE(-/-) mice by down-regulating PCSK9 via ERK1/2 pathway
por: Ma, Chun-Yan, et al.
Publicado: (2021)

LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis
por: Li, Gang, et al.
Publicado: (2023)

Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE(−/−) Mice
por: Ma, Chuanrui, et al.
Publicado: (2020)

Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
por: Wu, Hongyan, et al.
Publicado: (2021)

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis
por: Yu, Amy, et al.
Publicado: (2022)

Metformin intervention ameliorates AS in ApoE(-/-) mice through restoring gut dysbiosis and anti-inflammation
por: Yan, Ning, et al.
Publicado: (2021)

Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway
por: Yue, Si-Ran, et al.
Publicado: (2022)

Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
por: Zhang, Zhiguo, et al.
Publicado: (2016)

Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet
por: Peng, Jing-hua, et al.
Publicado: (2018)

Berberine ameliorates cellular senescence and extends the lifespan of mice via regulating p16 and cyclin protein expression
por: Dang, Yao, et al.
Publicado: (2019)

Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in the rat
por: Gao, Fei, et al.
Publicado: (2014)

Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
por: Park, Jung Gyu, et al.
Publicado: (2019)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
por: Cabrera, Daniel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hsv1qnfpceo8neh8bph61fjurp